Free Trial

Thermo Fisher Scientific (TMO) Stock Forecast & Price Target

$610.17
-4.37 (-0.71%)
(As of 08/21/2024 ET)

Thermo Fisher Scientific - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 18 Wall Street analysts who have issued ratings for Thermo Fisher Scientific in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 5 have given a hold rating, and 13 have given a buy rating for TMO.

Consensus Price Target

$618.94
1.44% Upside
High Forecast$670.00
Average Forecast$618.94
Low Forecast$475.00

According to the 18 analysts' twelve-month price targets for Thermo Fisher Scientific, the average price target is $618.94. The highest price target for TMO is $670.00, while the lowest price target for TMO is $475.00. The average price target represents a forecasted upside of 1.44% from the current price of $610.17.

TypeCurrent Forecast
8/23/23 to 8/22/24
1 Month Ago
7/24/23 to 7/23/24
3 Months Ago
5/25/23 to 5/24/24
1 Year Ago
8/23/22 to 8/23/23
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
12 Buy rating(s)
12 Buy rating(s)
11 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
5 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
1 Sell rating(s)
Consensus Price Target$618.94$605.63$607.35$633.50
Forecasted Upside1.44% Upside13.46% Upside13.69% Upside12.08% Upside
Get Thermo Fisher Scientific Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

TMO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TMO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Thermo Fisher Scientific Stock vs. The Competition

TypeThermo Fisher ScientificMedical CompaniesS&P 500
Consensus Rating Score
2.72
2.75
2.51
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside1.44% Upside5,586.21% Upside8.75% Upside
News Sentiment RatingPositive News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/25/2024TD Cowen
4 of 5 stars
 Boost TargetBuy ➝ Buy$648.00 ➝ $658.00+10.32%
7/25/2024Raymond James
4 of 5 stars
 Boost TargetOutperform ➝ Outperform$650.00 ➝ $660.00+9.56%
7/25/2024Royal Bank of Canada
4 of 5 stars
 Boost TargetOutperform ➝ Outperform$660.00 ➝ $664.00+10.67%
7/25/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$600.00 ➝ $615.00+3.47%
7/25/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$620.00 ➝ $632.00+9.95%
7/2/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$615.00 ➝ $600.00+11.45%
6/28/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight ➝ Equal Weight$615.00 ➝ $600.00+8.49%
6/3/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Buy$600.00 ➝ $650.00+14.44%
4/30/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$660.00 ➝ $670.00+17.13%
4/25/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$600.00 ➝ $610.00+6.54%
4/25/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$600.00 ➝ $650.00+12.53%
4/10/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$550.00 ➝ $640.00+10.94%
3/18/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageNeutral$620.00+6.70%
1/8/2024Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Market Perform
12/13/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$575.00+15.58%
10/26/2023KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Sector Weight
10/25/2023Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Equal Weight$475.00+11.02%
10/24/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$640.00 ➝ $600.00+29.92%
7/13/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Outperform$620.00+17.89%
2/2/2023SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$620.00 ➝ $630.00+7.26%
2/2/2023Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$690.00 ➝ $711.00+21.05%
10/27/2022Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 05:01 AM ET.

TMO Forecast - Frequently Asked Questions

What is Thermo Fisher Scientific's forecast for 2024?

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Thermo Fisher Scientific is $618.94, with a high forecast of $670.00 and a low forecast of $475.00.

Should I buy or sell Thermo Fisher Scientific stock right now?

18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last twelve months. There are currently 5 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TMO shares.

Does Thermo Fisher Scientific's stock price have much upside?

According to analysts, Thermo Fisher Scientific's stock has a predicted upside of 11.69% based on their 12-month stock forecasts.

What analysts cover Thermo Fisher Scientific?

Thermo Fisher Scientific has been rated by research analysts at Barclays, Evercore ISI, Jefferies Financial Group, Raymond James, Robert W. Baird, Royal Bank of Canada, Stifel Nicolaus, and TD Cowen in the past 90 days.

Do Wall Street analysts like Thermo Fisher Scientific more than its competitors?

Analysts like Thermo Fisher Scientific less than other "medical" companies. The consensus rating score for Thermo Fisher Scientific is 2.72 while the average consensus rating score for "medical" companies is 2.75. Learn more on how TMO compares to other companies.


This page (NYSE:TMO) was last updated on 8/22/2024 by MarketBeat.com Staff

From Our Partners